New DIY artificial pancreas guidance
Diabetes UK responds to new DIY artificial pancreas guidance published in The Lancet Diabetes & Endocrinology on Sunday (14 November) about guidance for people with type...
Pharmacy/Drugs
The Pharmacy & Drugs category covers the safe, effective and evidence-based use of medications and therapies. It explores how medicines work, current prescribing practices, regulatory developments and issues affecting access, safety and innovation. From insights on drug interactions and adherence to analysis of emerging treatments, this category supports informed decision-making for clinicians, pharmacists and healthcare consumers alike.
WHO: Barriers to insulin 100 years on
New WHO report maps barriers to insulin availability and suggests actions to promote universal access: 100 years after its discovery, insulin still out of reach for...
New tech wound healing
Safe and effective - wound healing preparation reaches clinical phase II: APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells....
Cell-based vaccine for children and adolescents
A cell-based influenza vaccine has effectively provided protection against the flu in children and adolescents, according to a new study. The research found the cell-based...
Personalized medicine study for cancer therapies
First worldwide personalized medicine study using a functional test demonstrates clinical feasibility and efficacy of individualized therapy in leukemia and lymphoma patients. Standard therapy for...
WHO recommends malaria vaccine for children at risk
WHO recommends ground breaking malaria vaccine for children at risk. Historic RTS,S/AS01 recommendation can reinvigorate the fight against malaria. The World Health Organization (WHO) is recommending...
WHO: new essential medicines list
WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists: High prices and low availability still a major barrier for patients’ access...
Merck and Ridgeback’s Antiviral Molnupiravir trial
News Release: Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients...
Monash University: Drug repurposing is no panacea in race to treat COVID-19
Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and there are inherent dangers and pitfalls with translating drugs such as...
Common antibiotic reduces low birth weight and prematurity
A common antibiotic has been found to reduce low birth weight and premature births, if taken during pregnancy, in countries where malaria is endemic, according...
